CD8+ T cells from most HIV-1-infected patients, even when challenged with mature dendritic cells, lack functional recall memory to HIV gag but not other viruses

被引:36
作者
Arrode, G
Finke, JS
Zebroski, H
Siegal, FP
Steinman, RM
机构
[1] Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10021 USA
[2] St Vincents Hosp & Med Ctr, Comprehens HIV Ctr, New York, NY 10011 USA
关键词
HIV-1; dendritic cells; CD8(+) T cell response; cellular proliferation;
D O I
10.1002/eji.200425744
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chronically HIV-1-infected patients fail to contain their viremia despite high frequencies of HIV-1-specific, IFN-gamma-producing CD8(+) T cells. However, these cells are known to exhibit both phenotypic and functional defects. We tested if mature dendritic cells (DC) could correct defective HIV-1 gag-specific T cell responses and if responses to other viral antigens were comparably affected. The circulating gag-specific CD8(+) T cells in fresh blood reliably produced IFN-gamma but lacked IL-2 and high perforin levels and failed to expand significantly during culture with mature DC presenting HIV-1 gag peptides. In contrast, CD8(+) T cells from long-term nonprogressors contained gag-specific IFN-gamma and IL-2 double producers, and the numbers of IFN-gamma producers expanded similar to15-fold during culture with DC. DC from chronically infected patients could expand IFN-gamma- and IL-2-producing cells specific for influenza, cytornegalovirus and Epstein Barr virus, and the expansions were comparable to those in healthy donors. When the proliferative capacity of CD8(+) T cells from progressor patients was assessed by CFSE dilution, proliferation to other viral antigens was more vigorous than to HIV-1 gag. Therefore, monocyte-derived DC from HIV patients present viral antigens effectively, but there is a selective inability to expand CD8(+) IFN-gamma-producing and IFN-gamma and IL-2 double-producing T cells when challenged with HIV-1 gag.
引用
收藏
页码:159 / 170
页数:12
相关论文
共 35 条
[1]   Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection [J].
Altfeld, M ;
Addo, MA ;
Rosenberg, ES ;
Hecht, FA ;
Lee, PK ;
Vogel, M ;
Yu, XG ;
Draenert, R ;
Johnston, MN ;
Strick, D ;
Allen, TA ;
Feeney, ME ;
Kahn, JO ;
Sekaly, RP ;
Levy, JA ;
Rockstroh, JK ;
Goulder, PJR ;
Walker, BD .
AIDS, 2003, 17 (18) :2581-2591
[2]   Phenotype and functional characteristics of HIV-specific cytotoxic CD8+ T cells in chronically infected patients -: Dual effects of highlyv active antiretroviral therapy [J].
Benito, JM ;
López, M ;
Lozano, S ;
Martinez, P ;
Kuroda, M ;
González-Lahoz, J ;
Soriano, V .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 34 (03) :255-266
[3]   Analysis of total human immunodeficiency virus (HIV)-specific CD4+ and CD8+ T-cell responses:: Relationship to viral load in untreated HIV infection [J].
Betts, MR ;
Ambrozak, DR ;
Douek, DC ;
Bonhoeffer, S ;
Brenchley, JM ;
Casazza, JP ;
Koup, RA ;
Picker, LJ .
JOURNAL OF VIROLOGY, 2001, 75 (24) :11983-11991
[4]   Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells [J].
Brenchley, JM ;
Karandikar, NJ ;
Betts, MR ;
Ambrozak, DR ;
Hill, BJ ;
Crotty, LE ;
Casazza, JP ;
Kuruppu, J ;
Migueles, SA ;
Connors, M ;
Roederer, M ;
Douek, DC ;
Koup, RA .
BLOOD, 2003, 101 (07) :2711-2720
[5]   Skewed maturation of memory HIV-specific CD8 T lymphocytes [J].
Champagne, P ;
Ogg, GS ;
King, AS ;
Knabenhans, C ;
Ellefsen, K ;
Nobile, M ;
Appay, V ;
Rizzardi, GP ;
Fleury, S ;
Lipp, M ;
Förster, R ;
Rowland-Jones, S ;
Sékaly, RP ;
McMichael, AJ ;
Pantaleo, G .
NATURE, 2001, 410 (6824) :106-111
[6]   A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays [J].
Currier, JR ;
Kuta, EG ;
Turk, E ;
Earhart, LB ;
Loomis-Price, L ;
Janetzki, S ;
Ferrari, G ;
Birx, DL ;
Cox, JH .
JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 260 (1-2) :157-172
[7]   Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection [J].
Draenert, R ;
Verrill, CL ;
Tang, Y ;
Allen, TM ;
Wurcel, AG ;
Boczanowski, M ;
Lechner, A ;
Kim, AY ;
Suscovich, T ;
Brown, NV ;
Addo, MM ;
Walker, BD .
JOURNAL OF VIROLOGY, 2004, 78 (02) :630-641
[8]  
Ellefsen K, 2002, EUR J IMMUNOL, V32, P3756, DOI 10.1002/1521-4141(200212)32:12<3756::AID-IMMU3756>3.0.CO
[9]  
2-E
[10]   Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities [J].
Frahm, N ;
Korber, BT ;
Adams, CM ;
Szinger, JJ ;
Draenert, R ;
Addo, MM ;
Feeney, ME ;
Yusim, K ;
Sango, K ;
Brown, NV ;
SenGupta, D ;
Piechocka-Trocha, A ;
Simonis, T ;
Marincola, FM ;
Wurcel, AG ;
Stone, DR ;
Russell, CJ ;
Adolf, P ;
Cohen, D ;
Roach, T ;
StJohn, A ;
Khatri, A ;
Davis, K ;
Mullins, J ;
Goulder, PJR ;
Walker, BD ;
Brander, C .
JOURNAL OF VIROLOGY, 2004, 78 (05) :2187-2200